RxDoctor Payments Data

Ethan Ross Dumayas, PA

Physician Assistant · Altoona, PANPI 1679175749

Payments from drug & device makers

$1,039in general payments, 2019–2025

Across 17 payments — averaging $61.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$464
  • Lilly USA, LLC$201
  • Pfizer$141
  • Sanofi-aventis U.S. LLC$97
  • GSK$67
  • Johnson & Johnson$19
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$1,039100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,039 in reported general payments places this provider in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$41,848
Medicare patients
301
Services billed
721

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin26$20,477
EliquisApixaban13$7,305
Gabapentin91$1,845
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav88$741
Prednisone250$725
Atorvastatin Calcium34$586
Cefdinir36$505
Doxycycline Hyclate78$502
Allopurinol26$479
Amlodipine Besylate72$466
Pantoprazole Sodium29$377
Potassium Chloride23$376
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$355
Duloxetine Hcl17$347
Lisinopril40$331

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$141$7,30513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Altoona

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →